Thomas Patrick Kelly - Jan 16, 2024 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Chief Financial Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jan 16, 2024
Transactions value $
-$35,234
Form type
4
Date filed
1/18/2024, 04:15 PM
Previous filing
Dec 14, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$35.2K -2.44K -3.55% $14.47 66.1K Jan 16, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock units.